Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

81 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Consensus Recommendations from the 2024 Lymphoma Research Foundation Workshop on Treatment Selection and Sequencing in CLL or SLL.
Soumerai JD, Barrientos JC, Ahn IE, Coombs CC, Gladstone DE, Hoffmann MS, Kittai AS, Jacobs RW, Lipsky A, Patel K, Rhodes JM, Skarbnik AP, Thompson MC, Ermann DA, Reville PK, Shah HR, Brown JR, Stephens DM. Soumerai JD, et al. Among authors: barrientos jc. Blood Adv. 2024 Nov 19:bloodadvances.2024014474. doi: 10.1182/bloodadvances.2024014474. Online ahead of print. Blood Adv. 2024. PMID: 39561376
Tolerability & long-term disease control by IGHV mutation status among CLL patients on ibrutinib arm of E1912.
Shanafelt TD, Wang XV, Hanson CA, Paietta E, O'Brien SM MD, Barrientos JC, Jelinek DF, Braggio E, Leis JF, Zhang C, Barr PM, Cashen AF, Mato AR, Singh AK, Mullane M, Little RF, Erba HP, Stone RM, Litzow MR, Tallman MS, Kay NE. Shanafelt TD, et al. Among authors: barrientos jc. Blood Adv. 2024 Aug 20:bloodadvances.2024013474. doi: 10.1182/bloodadvances.2024013474. Online ahead of print. Blood Adv. 2024. PMID: 39163612 No abstract available.
Real-World Treatment Patterns and Outcomes by Line of Therapy and Race in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Treated in the United States: Results From the Final Analysis of the Prospective, Observational, informCLL Registry.
Ghosh N, Sharman JP, Gutierrez M, Khan W, Qureshi ZP, Raz A, Girardi V, Krigsfeld GS, Barrientos JC. Ghosh N, et al. Among authors: barrientos jc. Clin Lymphoma Myeloma Leuk. 2024 Sep;24(9):e301-e313. doi: 10.1016/j.clml.2024.05.009. Epub 2024 May 13. Clin Lymphoma Myeloma Leuk. 2024. PMID: 38845276 Free article.
First-line ibrutinib treatment in patients with chronic lymphocytic leukemia is associated with overall survival rates similar to those of an age-matched general population: A pooled post hoc analysis.
Ghia P, Owen C, Allan JN, Barrientos JC, Barr PM, Shi C, Szoke A, Abbazio C, Krigsfeld GS, Burger JA. Ghia P, et al. Among authors: barrientos jc. Hemasphere. 2024 May 27;8(5):e74. doi: 10.1002/hem3.74. eCollection 2024 May. Hemasphere. 2024. PMID: 38803455 Free PMC article. No abstract available.
Pitfalls of Current Diagnostic Criteria of Tumor Lysis Syndrome.
Alhamid N, Sabbagh B, Alsarraj A, Lerma E, Caza T, Workeneh B, Barrientos JC, Jhaveri KD. Alhamid N, et al. Among authors: barrientos jc. Kidney Blood Press Res. 2024 Mar 12. doi: 10.1159/000538328. Online ahead of print. Kidney Blood Press Res. 2024. PMID: 38471470 Free article. Review.
MRD-directed therapy in CLL: ready for prime time?
Rhodes JM, Lopez CA, Barrientos JC. Rhodes JM, et al. Among authors: barrientos jc. Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):413-420. doi: 10.1182/hematology.2023000441. Hematology Am Soc Hematol Educ Program. 2023. PMID: 38066928 Free PMC article. Review.
Characterization of the Intraclonal Complexity of Chronic Lymphocytic Leukemia B Cells: Potential Influences of B-Cell Receptor Crosstalk with Other Stimuli.
Mazzarello AN, Fitch M, Cardillo M, Ng A, Bhuiya S, Sharma E, Bagnara D, Kolitz JE, Barrientos JC, Allen SL, Rai KR, Rhodes J, Hellerstein MK, Chiorazzi N. Mazzarello AN, et al. Among authors: barrientos jc. Cancers (Basel). 2023 Sep 25;15(19):4706. doi: 10.3390/cancers15194706. Cancers (Basel). 2023. PMID: 37835400 Free PMC article.
81 results